New evidence layer and UK acquisition expand Heidi’s role across the clinical workflow
MELBOURNE, Australia - February 24, 2026 - Heidi, the leading healthcare AI platform, today announced major milestones in its mission to redefine how healthcare is delivered: the launch of Heidi Evidence and the acquisition of UK-based clinical AI pioneer AutoMedica. This comes alongside the launch of Heidi Comms, an AI partner for healthcare teams to coordinate patient communications across calls, bookings, reminders and follow-ups.
These moves mark Heidi’s evolution from an AI scribe into a comprehensive AI Care Partner, bridging the gap between clinical documentation and real-time clinical reasoning. Clinical evidence underpins everyday decisions in patient care, from confirming diagnoses and selecting treatments to determining dosages, follow-up plans, and safety considerations.
"We believe that for AI to be a true care partner, the integrity of its evidence must be non-negotiable," said Dr. Thomas Kelly, Co-Founder and CEO of Heidi. "As we see more general-purpose AI platforms like OpenAI move toward ad-supported models, consumers are rightly concerned about hidden influence.
In a healthcare setting, that concern becomes paramount. Bringing transparent, clinical-grade insights into the room makes it easier to deliver quality care, but that information must be free from the ambiguity of commercial influence. By committing to Evidence being ad-free and independent, we ensure clinicians can stay present with their patients, knowing their decision-making is built on pure clinical rigor, not a business model."
Heidi Evidence: Bridging the "Knowledge Gap" at the Point of Care
Medical knowledge now doubles every 73 days, making it impossible for clinicians to stay updated with new methods and research. While many have turned to general-purpose AI, these tools lack transparency and local clinical context. This "search engine" approach often erodes the perceived authority of the encounter, leading to a profound lack of patient comfort when they feel their symptoms are being researched via the same tools they use at home.
